Core Viewpoint - The stock of iFlytek Medical Technology (02506) has risen over 10%, currently trading at 89 HKD with a transaction volume of 53.94 million HKD, following the launch of OpenAI's ChatGPT Health feature, which is similar to Ant Group's AI health assistant [1][1][1] Group 1: Company Developments - On January 8, OpenAI launched the ChatGPT Health feature, designed to answer health-related questions, connect smart devices, and plan diet and exercise, creating a dedicated space for health-related conversations within ChatGPT [1][1] - Ant Group's AI health assistant has been rebranded as "Antifufu," linking to 5,000 hospitals and 300,000 real doctors for online consultations, and supporting integration with major smart device brands [1][1] - iFlytek Medical Technology is set to release the "iFlytek Spark Medical Model X1" based on deep reasoning technology in March 2025, which is the only medical deep reasoning model trained entirely on domestically sourced computing power [1][1] Group 2: Performance Metrics - In real-world testing, the general diagnostic accuracy of the iFlytek Spark Medical Model reached 94.0% [1][1] - The iFlytek Spark Medical Model underwent a capability upgrade in July 2025, with multiple performance indicators further improved [1][1] Group 3: Industry Outlook - Southwest Securities believes that AI in healthcare is a clear policy growth direction, and iFlytek, as a leading player, stands to benefit significantly [1][1] - The company possesses self-developed foundational models, with continuous improvements in performance capabilities, suggesting a positive outlook for ongoing investment interest [1][1]
港股异动 | 讯飞医疗科技(02506)涨超10% OpenAI发布ChatGPT Health 公司有望充分受益AI医疗发展